Literature DB >> 21212756

Viral factors and outcomes of chronic HBV infection.

Yuehua Huang, Anna S F Lok.   

Abstract

Viral factors associated with outcome of chronic hepatitis B virus (HBV) infection include hepatitis B e antigen status, HBV DNA, genotype, and HBV variants. Mutations in the HBV core promoter region have been shown to be independently associated with hepatocellular carcinoma (HCC). The most common core promoter mutations involve a double substitution A1762T and G1764A (TA). Besides TA mutations, several other core promoter changes have been reported to be associated with the development of cirrhosis and HCC. Future studies should determine if detection of these changes can predict the outcome of patients with chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212756     DOI: 10.1038/ajg.2010.404

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan.

Authors:  Abbas Ali Husseini; Khwaja Mir Islam Saeed; Esra Yurdcu; A Mithat Bozdayı
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

2.  Correlations of IFN-γ-inducible protein-10 with the risk of chronic hepatitis B and the efficacy of interferon therapy in Asians.

Authors:  Lu-Lu Gong; Bin-Bin Zhao; Wen-Feng Fan; Lu-Yu Gong; Cai-Feng Chen; Jing-Jun Liu; Xuan Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

3.  Hepatitis B virus and hepatitis C virus infections in United States-bound refugees from Asia and Africa.

Authors:  Tonya Mixson-Hayden; Deborah Lee; Lilia Ganova-Raeva; Jan Drobeniuc; William M Stauffer; Eyasu Teshale; Saleem Kamili
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

4.  Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection.

Authors:  En-Qiang Chen; Hui Sun; Ping Feng; Dao-Yin Gong; Cong Liu; Lang Bai; Wen-Bing Yang; Xue-Zhong Lei; Li-Yu Chen; Fei-Jun Huang; Hong Tang
Journal:  Virol J       Date:  2012-01-18       Impact factor: 4.099

5.  Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems.

Authors:  Ling-Yun Zhou; En-Qiang Chen; Meng-Lan Wang; Lan-Lan Chen; Cui-Ping Liu; Fan Zeng; Hong Tang
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

6.  Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.

Authors:  Miao Liu; Lingyao Du; Zhiliang He; Libo Yan; Ying Shi; Jin Shang; Hong Tang
Journal:  Biomed Res Int       Date:  2017-03-08       Impact factor: 3.411

7.  GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.

Authors:  Xiaojuan Wu; Hongbo Wang; Yifan Lian; Lubiao Chen; Lin Gu; Jialiang Wang; Yanlin Huang; Meihai Deng; Zhiliang Gao; Yuehua Huang
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

8.  Effects of hepatitis B virus mutations on its replication and liver disease severity.

Authors:  Abdulrahim Hakami; Abdelwahid Ali; Ahmed Hakami
Journal:  Open Virol J       Date:  2013-01-23

9.  Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans.

Authors:  Qi Wang; Paul Schwarzenberger; Fang Yang; Jingjing Zhang; Jianjia Su; Chun Yang; Ji Cao; Chao Ou; Liang Liang; Junlin Shi; Fang Yang; Duoping Wang; Jia Wang; Xiaojuan Wang; Ping Ruan; Yuan Li
Journal:  Virol J       Date:  2012-08-23       Impact factor: 4.099

10.  High prevalence of hepatitis B virus genotype C/C1 in the Minangkabau ethnic group in Indonesia.

Authors:  Marlinang D Siburian; Andi Utama; Rama Dhenni; Null Arnelis; Ismail Fanany; Mariana D B Intan; Tri S Kurniasih; Febi Andriani; Szeifoul Afadlal; Erlys B Julianto; Widyarman S Rasman; Nasrul Zubir; George Mathew
Journal:  Virol J       Date:  2013-01-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.